Literature DB >> 17199237

Dissatisfaction with performance of valued activities predicts depression in age-related macular degeneration.

Barry W Rovner1, Robin J Casten, Mark T Hegel, Walter W Hauck, William S Tasman.   

Abstract

OBJECTIVE: To determine whether dissatisfaction with performance of valued activities predicts depression in patients with age-related macular degeneration (AMD). PATIENTS: Two hundred and six patients with newly diagnosed neovascular AMD in one eye and pre-existing AMD in the fellow eye who were participating in a clinical trial of a psychosocial intervention to prevent depression. MEASURES: Structured clinical evaluations of vision function, depression, visual acuity, contrast sensitivity and medical morbidity. Subjects were classified as dissatisfied if they indicated that they were dissatisfied with their performance of a valued activity.
RESULTS: Subjects who were dissatisfied with performance of valued activities (n = 71) had similar demographic characteristics to satisfied subjects (n = 135) but had worse visual acuity (p < 0.054), greater medical comorbidity (p < 0.006), and lower vision function (p < 0.001). Dissatisfied subjects were almost 2.5 times more likely (OR = 2.41; [95% CI 1.02, 5.65]; p = 0.044) to become depressed within 2 months than satisfied subjects independent of baseline visual acuity, vision function, and medical comorbidity.
CONCLUSION: Dissatisfaction with performance of valued activities in older persons with AMD predicts depression over a 2-month period. Assessing the ability to pursue valued activities may identify patients at risk for depression and prompt clinicians to initiate rehabilitative interventions and careful surveillance for depression.

Entities:  

Mesh:

Year:  2007        PMID: 17199237     DOI: 10.1002/gps.1742

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  7 in total

1.  Applying theories and interventions from behavioral medicine to understand and reduce visual field variability in patients with vision loss.

Authors:  Collin Rozanski; Jennifer A Haythornthwaite; Gislin Dagnelie; Ava K Bittner
Journal:  Med Hypotheses       Date:  2014-05-09       Impact factor: 1.538

2.  [The influence of visual rehabilitation on secondary depressive disorders due to age-related macular degeneration. A randomized controlled pilot study].

Authors:  A Mielke; K Wirkus; R Niebler; G Eschweiler; N X Nguyen; S Trauzettel-Klosinski
Journal:  Ophthalmologe       Date:  2013-05       Impact factor: 1.059

3.  Depression in Age-Related Macular Degeneration.

Authors:  Robin Casten; Barry Rovner
Journal:  J Vis Impair Blind       Date:  2008

4.  Longitudinal incidence of adverse outcomes of age-related macular degeneration.

Authors:  Ashley Wysong; Paul P Lee; Frank A Sloan
Journal:  Arch Ophthalmol       Date:  2009-03

5.  Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008.

Authors:  Xinzhi Zhang; Kai McKeever Bullard; Mary Frances Cotch; M Roy Wilson; Barry W Rovner; Gerald McGwin; Cynthia Owsley; Lawrence Barker; John E Crews; Jinan B Saaddine
Journal:  JAMA Ophthalmol       Date:  2013-05       Impact factor: 7.389

6.  The direction of research into visual disability and quality of life in glaucoma.

Authors:  Fiona C Glen; David P Crabb; David F Garway-Heath
Journal:  BMC Ophthalmol       Date:  2011-08-04       Impact factor: 2.209

7.  Functional Outcomes of the Low Vision Depression Prevention Trial in Age-Related Macular Degeneration.

Authors:  Ashley D Deemer; Robert W Massof; Barry W Rovner; Robin J Casten; Catherine V Piersol
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-03-01       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.